Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-10-25

Clinical Trial Update: A Pilot Study of the Treatment of Central Serous Chorioretinopathy With Ketoconazole [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 pilot trial evaluating ketoconazole as a treatment for chronic central serous chorioretinopathy. The trial was…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketoconazole (Ketoconazole)

Snippet

Sponsor: Manhattan Eye, Ear & Throat Hospital | Conditions: Chronic Central Serous Chorioretinopathy | Phase 2 | Status: COMPLETED